Company profile
Clearmind Medicine Inc.
NASDAQ:CMNDBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05913752 | phase1_2 | recruiting | 2025-04-30 | 2026-12-31 | Clearmind Medicine Inc. | A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects |
FDA applications (0)
No records yet.